A glutaminase inhibitor
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

6-diazo-5-oxo-L-nor-Leucine

Item No. 17580

Technical Information
Formal Name
6-diazo-5-oxo-L-norleucine
CAS Number
157-03-9
Synonyms
  • DON
  • NSC 7365
Molecular Formula
C6H9N3O3
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMSO: 1 mg/mlPBS (pH 7.2): 10 mg/ml
λmax
274 nm
SMILES
OC([C@@H](N)CCC(C=[N+]=[N-])=O)=O
InChi Code
InChI=1S/C6H9N3O3/c7-5(6(11)12)2-1-4(10)3-9-8/h3,5H,1-2,7H2,(H,11,12)/t5-/m0/s1
InChi Key
YCWQAMGASJSUIP-YFKPBYRVSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    6-Diazo-5-oxo-L-nor-Leucine (DON) is a glutamine analog that inhibits glutaminases (Ki = 6 µM) and other glutamine-utilizing enzymes, including cytidine triphosphate synthase (CTPS), which uses glutamine in the synthesis of CTP.1,2,3 DON is commonly used in cells or tissues but its use in whole animals is limited by its teratogenicity.3,4,5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Willis, R.C., and Seegmiller, J.E. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast. J. Cell Physiol. 93, 375-382 (1977).

    2. Thangavelu, K., Chong, Q.Y., Low, B.C., et alStructural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA). Sci. Rep. 4, 1-7 (2014).

    3. Thomas, A.G., Rojas, C., Tanega, C., et alKinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors. Biochem. Biophys. Res. Commun. 438(2), 243-248 (2013).

    4. Botman, D., Tigchelaar, W., and Van Noorden, C.J.F. Determination of phosphate-activated glutaminase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry). J. Histochem. Cytochem. 62(11), 813-826 (2014).

    5. Greene, R.M., and Kochhar, D.M. Limb development in mouse embryos: Protection against teratogenic effects of 6-diazo-5-ox-ʟ-norleucine (DON) in vivo and in vitro. J. Embryol. Exp. Morphol. 33(2), 355-370 (1975).